PATIENT-REPORTED OUTCOMES FOLLOWING DISCONTINUATION OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB: RESULTS FROM A RANDOMISED CONTROLLED TRIAL

被引:0
作者
Kremer, J. [1 ,2 ]
Rigby, W. [3 ]
Singer, N. [4 ,5 ]
Birchwood, C. [6 ]
Gill, D. [6 ]
Reiss, W. [6 ]
Best, J. [6 ]
Pei, J. [6 ]
Michalska, M. [6 ]
机构
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Ctr Rheumatol, Albany, NY USA
[3] Dartmouth Coll, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
[5] MetroHlth Syst, Cleveland, OH USA
[6] Genentech Inc, San Francisco, CA 94080 USA
关键词
MONOTHERAPY;
D O I
10.1136/annrheumdis-2018-eular.1838
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0448
引用
收藏
页码:1386 / 1387
页数:3
相关论文
共 4 条
[1]  
Deshpande Prasanna R, 2011, Perspect Clin Res, V2, P137, DOI 10.4103/2229-3485.86879
[2]   Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) [J].
Dougados, Maxime ;
Kissel, Karsten ;
Sheeran, Tom ;
Tak, Paul P. ;
Conaghan, Philip G. ;
Martin Mola, Emilio ;
Schett, Georg ;
Amital, Howard ;
Navarro-Sarabia, Federico ;
Hou, Antony ;
Bernasconi, Corrado ;
Huizinga, T. W. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (01) :43-50
[3]   Patient-reported outcomes in rheumatoid arthritis [J].
Her, Minyoung ;
Kavanaugh, Arthur .
CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) :327-334
[4]   Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate-and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study [J].
Jones, Graeme ;
Wallace, Thomas ;
McIntosh, Matthew J. ;
Brockwell, Laura ;
Gomez-Reino, Juan J. ;
Sebba, Anthony .
JOURNAL OF RHEUMATOLOGY, 2017, 44 (02) :142-146